NCT06501859

Brief Summary

The investigators purpose of the proposed study is to use the FDA approved Shoulder Pacemaker device in patients undergoing reverse shoulder arthroplasty and study the functional outcomes compared to a standard post-operative rehabilitation program. The investigators hypothesize that use of the Shoulder Pacemaker reduce pain and will allow for improved range of motion and function in patients undergoing RSA. The findings of this research may very well improve function in RSA patients through a novel, non-invasive approach.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Aug 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Aug 2023Jul 2027

Study Start

First participant enrolled

August 2, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

July 8, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 15, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

October 29, 2025

Status Verified

October 1, 2025

Enrollment Period

3.9 years

First QC Date

July 8, 2024

Last Update Submit

October 27, 2025

Conditions

Keywords

Reverse Shoulder Arthroplasty (RSA)Shoulder PacemakerRehabilitationRange of motionPain

Outcome Measures

Primary Outcomes (5)

  • American Shoulder and Elbow Surgeons score

    Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.

    Pre-operatively

  • American Shoulder and Elbow Surgeons score

    Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.

    6 weeks after surgery

  • American Shoulder and Elbow Surgeons score

    Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.

    3 months after surgery

  • American Shoulder and Elbow Surgeons score

    Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.

    6 months after surgery

  • American Shoulder and Elbow Surgeons score

    Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.

    1 year after surgery

Study Arms (2)

Standard of care physical therapy

ACTIVE COMPARATOR

Control group and will not use the shoulder pacemaker, but will participate in a standardized physical therapy protocol for 3 months.

Other: Standard of care physical therapy

Shoulder pacemaker with physical therapy

EXPERIMENTAL

Include a standardized physical therapy protocol with utilization of the Shoulder Pacemaker device 3 times per week over a 3-month period starting at 6 weeks post-operatively.

Device: Shoulder pacemaker with physical therapy

Interventions

Standard rehabilitation protocol for 3 months.

Standard of care physical therapy

Standardized rehabilitation protocol with utilization of the shoulder pacemaker device 3 times per week over a 3-month period.

Shoulder pacemaker with physical therapy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients indicated for primary reverse shoulder arthroplasty
  • Surgery at University of Utah Facilities
  • Patients between the ages 18-80.

You may not qualify if:

  • Prior ipsilateral shoulder arthroplasty
  • Inability or unwillingness to participate in the rehabilitation protocol
  • Prior cardiac pacemaker or spinal cord stimulator
  • Age over 80
  • History of periscapular surgery
  • History of ipsilateral neurologic injury
  • Prisoners
  • Patients requiring prolonged immobilization deviating from standard protocol
  • Patients who have an implantable medical device or other electrical device.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Utah Orthopedics

Salt Lake City, Utah, 84108, United States

Location

MeSH Terms

Conditions

Shoulder InjuriesPain

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Wounds and InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Officials

  • Christopher Joyce, M.D.

    University of Utah Orthopaedics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

July 8, 2024

First Posted

July 15, 2024

Study Start

August 2, 2023

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

October 29, 2025

Record last verified: 2025-10

Locations